LOS ANGELES, July 23, 2021 /PRNewswire/ -- ImaginAb Inc, a market leading global biotechnology company, focused on developing next generation immuno oncology imaging agents and therapeutic radiopharmaceuticals (RPT), today announced the signing of a new significant multi-year,...
from PR Newswire: https://ift.tt/3kJZcQL
No comments:
Post a Comment